ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+113.1%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+113.1%/yr
vs +3.0%/yr prior
Acceleration
+110.1pp
Accelerating
Percentile
P71
Within normal range
vs 3Y Ago
9.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.07M | -29.0% |
| 2024 | $11.37M | -13.6% |
| 2023 | $13.15M | +1477.3% |
| 2022 | $834000.00 | +205.7% |
| 2021 | $-789000.00 | -32.4% |
| 2020 | $-596000.00 | -696.0% |
| 2019 | $100000.00 | -86.5% |
| 2018 | $741000.00 | - |